Iridex reiterated its financial outlook for 2023, expecting Cyclo G6 probe sales of 65,000 to 67,000 representing approximately 9% to 12% growth over 2022 and to expand the Cyclo G6 systems installed base by 225 to 250 systems. Total revenue for the full year is expected to be $57 million to $59 million. 2023 total revenue guidance represents growth of approximately 3% to 6% after adjusting for an approximate $1.5 million reduction of Other Revenue royalty income resulting from the expiration of licensed patents.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
2.65 USD | -13.96% | -6.69% | -5.69% |
05-14 | Transcript : IRIDEX Corporation, Q1 2024 Earnings Call, May 14, 2024 | |
05-14 | Earnings Flash (IRIX) IRIDEX CORPORATION Posts Q1 Revenue $11.8M, vs. Street Est of $12M | MT |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-5.69% | 50.06M | |
+12.85% | 227B | |
+13.88% | 192B | |
+18.39% | 136B | |
+28.78% | 108B | |
+1.67% | 64.07B | |
+18.24% | 52.1B | |
+7.04% | 51.87B | |
+10.83% | 44.33B | |
+5.94% | 36.75B |
- Stock Market
- Equities
- IRIX Stock
- News IRIDEX Corporation
- IRIDEX Corporation Reiterates Financial Guidance for 2023